Renalogic is a key player in the Health Care sector, specializing in managing risks related to dialysis and Chronic Kidney Disease (CKD). Founded in 2002, the company is headquartered in the United States and leads through proprietary solutions in repricing, risk-stratification, and specialty case management.
Their comprehensive approach integrates renal risk analytics, case management, and dialysis cost containment. The team's expertise spans healthcare administration, clinical renal disease expertise, and legal knowledge concerning ERISA and healthcare law.
Renalogic provides a range of services, including cost containment, risk analysis, CKD management, and educational resources for members, ensuring improved patient care and reduced healthcare costs.
Backed by a recent venture round investment from Carrick Capital Partners on 03 March 2021, Renalogic is poised for further growth in transforming renal disease management and cost efficiency.